Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  ImmunoCellular Therapeutics Ltd    IMUC

Delayed Quote. Delayed  - 05/27 10:02:01 pm
0.235 USD   -1.67%
05/23 IMMUNOCELLULAR : to Present at Marcum MicroCap Conference on June 2..
05/19 IMMUNOCELLULAR : BioLife Solutions and MNX Global Logistics Partner..
05/12 IMMUNOCELLULAR : Announces First Quarter 2016 Financial Results
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse Mkt
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
0.21(c) 0.2128(c) 0.225(c) 0.239(c) 0.235(c) Last
547 320 733 483 701 308 510 322 210 231 Volume
-2.33% +1.33% +5.73% +6.22% -1.67% Change
More quotes
Financials ($)
Sales 2016 -
EBIT 2016 -24,8 M
Net income 2016 -25,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -26,3 M
Net income 2017 -27,4 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0
Capi. / Sales 2017 0
Capitalization 22,3 M
More Financials
Company
ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that develops immune-based therapies for the treatment of brain and other cancers.ImmunoCellular's pipeline includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent... 
More about the company
Latest news on IMMUNOCELLULAR THERAPEUTIC
05/23 IMMUNOCELLULAR THERAPEUTICS : to Present at Marcum MicroCap Conference on June 2..
05/19 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2016 Financial Results
05/19 IMMUNOCELLULAR THERAPEUTICS : BioLife Solutions and MNX Global Logistics Partner..
05/13 IMMUNOCELLULAR THERAPEUTICS : Management's Discussion and Analysis of Financial ..
05/12 IMMUNOCELLULAR THERAPEUTICS, LTD. : Results of Operations and Financial Conditio..
05/12 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2016 Financial Results
05/12 IMMUNOCELLULAR THERAPEUTICS : Receives Regulatory Approval in Canada, the UK and..
05/12 IMMUNOCELLULAR THERAPEUTICS : Announces First Quarter 2016 Financial Results
05/06 IMMUNOCELLULAR THERAPEUTICS : Receives Regulatory Approval in Canada, the UK and..
05/04 IMMUNOCELLULAR THERAPEUTICS : to Report First Quarter 2016 Financial Results on ..
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
05/12 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q1 2016 Results - Ea..
05/12 ImmunoCellular Therapeutics beats by $0.01
03/31 ImmunoCellular Therapeutics' (IMUC) CEO Andrew Gengos on Q4 2015 Results - Ea..
03/31 ImmunoCellular Therapeutics reports FY15 results
03/30 ImmunoCellular Therapeutics EPS in-line
Advertisement
Chart IMMUNOCELLULAR THERAPEUTIC
Duration : Period :
ImmunoCellular Therapeutic Technical Analysis Chart | IMUC | US4525361055 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions